Efficacy and safety of ATA129, partially matched allogeneic third-party Epstein-Barr virus-targeted cytotoxic T lymphocytes in a multicenter study for post transplant lymphoproliferative disorder Meeting Abstract


Authors: Prockop, S. E.; Li, A.; Baiocchi, R.; Bunin, N. J.; Mahadeo, K. M.; Nemecek, E. R.; Nikiforow, S.; Reshef, R.; Tsai, D. E.; Navarro, W. H.; O'Reilly, R. J.
Abstract Title: Efficacy and safety of ATA129, partially matched allogeneic third-party Epstein-Barr virus-targeted cytotoxic T lymphocytes in a multicenter study for post transplant lymphoproliferative disorder
Meeting Title: 2018 BMT Tandem Meetings
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 24
Issue: 3 Suppl. 1
Meeting Dates: 2018 Feb 21-25
Meeting Location: Salt Lake City, UT
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2018-03-01
Start Page: S35
End Page: S36
Language: English
ACCESSION: WOS:000425476000025
PROVIDER: wos
DOI: 10.1016/j.bbmt.2017.12.595
Notes: Meeting Abstract: 21 -- Meeting date is incorrect in the original publication's table of contents -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Susan E Prockop
    262 Prockop
  2. Richard O'Reilly
    747 O'Reilly